{"transactions":[{"id":736164,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:21:17.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001606244-26-000004","document":"wk-form4_1781641275.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000160624426000004/wk-form4_1781641275.xml","form_type":"4"}},{"id":736163,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:21:17.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will\nfully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. Pursuant to the Issuer's Nonqualified RSU Deferral Program for Non-Employee Directors, the Reporting Person has deferred delivery of all of such vested RSUs to the earlier of (i) a separation from service, or (ii) a qualifying change in control."}],"balance_after":6856,"source":{"system":"sec-edgar","filing":"0001606244-26-000004","document":"wk-form4_1781641275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000160624426000004/wk-form4_1781641275.xml","form_type":"4"}},{"id":774715,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:24.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":8741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":28323,"source":{"system":"sec-edgar","filing":"0001606244-26-000002","document":"form4-05182026_040514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000160624426000002/form4-05182026_040514.xml","form_type":"4"}},{"id":1109750,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T22:05:35.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":15372,"derivative":{"exercise_price":34.46,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":15372},"source":{"system":"sec-edgar","filing":"0001606244-25-000003","document":"wk-form4_1750111529.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000160624425000003/wk-form4_1750111529.xml","form_type":"4"}},{"id":1109749,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T22:05:35.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":3041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":4591,"source":{"system":"sec-edgar","filing":"0001606244-25-000003","document":"wk-form4_1750111529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000160624425000003/wk-form4_1750111529.xml","form_type":"4"}},{"id":1142357,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:37:56.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":19582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. 9,791 of the RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders; 9,791 of the RSUs vest on May 15, 2026, in each case subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":19582,"source":{"system":"sec-edgar","filing":"0001062993-25-009804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325009804/form4.xml","form_type":"4"}},{"id":1337177,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-10T21:14:54.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the sole benefit of the Reporting Person."}],"balance_after":7250,"derivative":{"exercise_price":72.51,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001649094-24-000122","document":"wk-form4_1733865288.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000122/wk-form4_1733865288.xml","form_type":"4"}},{"id":1337176,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-10T21:14:54.000Z","date":"2024-12-09","kind":"gift","planned":false,"acquired":false,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"exercise_price":72.51,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001649094-24-000122","document":"wk-form4_1733865288.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000122/wk-form4_1733865288.xml","form_type":"4"}},{"id":1337175,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-10T21:14:54.000Z","date":"2024-12-06","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the sole benefit of the Reporting Person."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001649094-24-000122","document":"wk-form4_1733865288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000122/wk-form4_1733865288.xml","form_type":"4"}},{"id":1337174,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-10T21:14:54.000Z","date":"2024-12-06","kind":"gift","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As previously disclosed in Reporting Person's Form 4 filed on June 10, 2024, this represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":1550,"source":{"system":"sec-edgar","filing":"0001649094-24-000122","document":"wk-form4_1733865288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000122/wk-form4_1733865288.xml","form_type":"4"}},{"id":1484885,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:05:43.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":7250,"derivative":{"exercise_price":72.51,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001649094-24-000009","document":"wk-form4_1718049932.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000009/wk-form4_1718049932.xml","form_type":"4"}},{"id":1484884,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:05:43.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":4050,"source":{"system":"sec-edgar","filing":"0001649094-24-000009","document":"wk-form4_1718049932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000009/wk-form4_1718049932.xml","form_type":"4"}},{"id":1745724,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-09T21:36:46.000Z","date":"2023-11-09","kind":"gift","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Options are held directly by a trust for the sole benefit of the Reporting Person."}],"balance_after":15000,"derivative":{"exercise_price":53.08,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-054846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123054846/doc4.xml","form_type":"4"}},{"id":1745723,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-09T21:36:46.000Z","date":"2023-11-09","kind":"gift","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"exercise_price":53.08,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-054846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123054846/doc4.xml","form_type":"4"}},{"id":1745722,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-09T21:36:46.000Z","date":"2023-11-09","kind":"gift","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Common Stock subject to the option vested fully on June 1, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Options are held directly by a trust for the sole benefit of the Reporting Person."}],"balance_after":18750,"derivative":{"exercise_price":22.7,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-23-054846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123054846/doc4.xml","form_type":"4"}},{"id":1745721,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-09T21:36:46.000Z","date":"2023-11-09","kind":"gift","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of Common Stock subject to the option vested fully on June 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":22.7,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-23-054846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123054846/doc4.xml","form_type":"4"}},{"id":1745720,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-09T21:36:46.000Z","date":"2023-11-09","kind":"gift","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Options are held directly by a trust for the sole benefit of the Reporting Person."}],"balance_after":30000,"derivative":{"exercise_price":22.02,"expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-054846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123054846/doc4.xml","form_type":"4"}},{"id":1745719,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-09T21:36:46.000Z","date":"2023-11-09","kind":"gift","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":0,"derivative":{"exercise_price":22.02,"expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-054846","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123054846/doc4.xml","form_type":"4"}},{"id":1745718,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T21:36:46.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares are held directly by a trust for the sole benefit of the Reporting Person."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-23-054846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123054846/doc4.xml","form_type":"4"}},{"id":1745717,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T21:36:46.000Z","date":"2023-11-09","kind":"gift","planned":false,"acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As previously disclosed in Reporting Person's Form 4 filed on June 15, 2023, this represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-23-054846","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123054846/doc4.xml","form_type":"4"}},{"id":1852818,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-17T00:44:49.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":35380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly increments beginning on July 14, 2023 subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":35380,"derivative":{"exercise_price":2.18,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":35380},"source":{"system":"sec-edgar","filing":"0001162194-23-000044","document":"wk-form4_1686962679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000044/wk-form4_1686962679.xml","form_type":"4"}},{"id":1852817,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-17T00:44:49.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":26376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of Restricted Stock Units. Each Restricted Stock Unit represents the right to receive one share of common stock upon vesting. The Restricted Stock Units vest in full on the earlier to occur of June 14, 2024 and one day prior to the date of the Company's next annual meeting of stockholders subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":126844,"source":{"system":"sec-edgar","filing":"0001162194-23-000044","document":"wk-form4_1686962679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219423000044/wk-form4_1686962679.xml","form_type":"4"}},{"id":1854292,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T21:51:27.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":15000,"derivative":{"exercise_price":53.08,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-037497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123037497/doc4.xml","form_type":"4"}},{"id":1854291,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:51:27.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001209191-23-037497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123037497/doc4.xml","form_type":"4"}},{"id":2228392,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T22:05:14.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":42571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022."}],"balance_after":42571,"derivative":{"exercise_price":1.86,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":42571},"source":{"system":"sec-edgar","filing":"0001162194-22-000077","document":"wf-form4_165550349980323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000077/wf-form4_165550349980323.xml","form_type":"4"}},{"id":2228391,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T22:05:14.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":30914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":100468,"source":{"system":"sec-edgar","filing":"0001162194-22-000077","document":"wf-form4_165550349980323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219422000077/wf-form4_165550349980323.xml","form_type":"4"}},{"id":2244717,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:33:39.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":18750,"derivative":{"exercise_price":22.7,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-22-034069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122034069/doc4.xml","form_type":"4"}},{"id":2244716,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:33:39.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-22-034069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122034069/doc4.xml","form_type":"4"}},{"id":2531856,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-29T22:12:25.000Z","date":"2021-10-27","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option shall vest over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date"}],"balance_after":30000,"derivative":{"exercise_price":22.02,"expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-062120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121062120/doc4.xml","form_type":"4"}},{"id":2693780,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-27T21:32:31.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":15402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly increments beginning on June 25, 2021."}],"balance_after":15402,"derivative":{"exercise_price":5.56,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":15402},"source":{"system":"sec-edgar","filing":"0001162194-21-000062","document":"wf-form4_162215106853926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000062/wf-form4_162215106853926.xml","form_type":"4"}},{"id":2693779,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T21:32:31.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":10342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units vest in full on the earlier to occur of May 25, 2022 and one day prior to the date of the Company's next annual meeting of stockholders."}],"balance_after":69554,"source":{"system":"sec-edgar","filing":"0001162194-21-000062","document":"wf-form4_162215106853926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000062/wf-form4_162215106853926.xml","form_type":"4"}},{"id":2772230,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-03-25T21:10:08.000Z","date":"2021-03-23","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units vesting as to 25% of the shares underlying the Restricted Stock Units on each anniversary date after the date of grant on the same day of the month as the date of grant, subject to continued service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units vesting as to 25% of the shares underlying the Restricted Stock Units on each anniversary date after the date of grant on the same day of the month as the date of grant, subject to continued service as a director."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001162194-21-000017","document":"wf-form4_161670659416602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000017/wf-form4_161670659416602.xml","form_type":"4"}},{"id":2772229,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T21:10:08.000Z","date":"2021-03-23","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":59212,"source":{"system":"sec-edgar","filing":"0001162194-21-000017","document":"wf-form4_161670659416602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219421000017/wf-form4_161670659416602.xml","form_type":"4"}},{"id":2785464,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-16T20:26:29.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":16614,"price":0.4042,"value":6715.3788,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents a weighted average. The shares were sold in multiple transactions at prices ranging from $0.40 to $0.41, inclusive. Mr. Paya will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950138-21-000224","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013821000224/edgar.xml","form_type":"4"}},{"id":3100058,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T20:00:19.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":20993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly increments beginning on July 23, 2020."}],"balance_after":20993,"derivative":{"exercise_price":3.74,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":20993},"source":{"system":"sec-edgar","filing":"0001162194-20-000085","document":"wf-form4_159311519874436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000085/wf-form4_159311519874436.xml","form_type":"4"}},{"id":3100057,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-25T20:00:19.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":13369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units vest in full on the earlier to occur of June 23, 2021 and one day prior to the date of the Company's next annual meeting of stockholders."}],"balance_after":56712,"source":{"system":"sec-edgar","filing":"0001162194-20-000085","document":"wf-form4_159311519874436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000085/wf-form4_159311519874436.xml","form_type":"4"}},{"id":3146813,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-15T20:32:33.000Z","date":"2020-05-13","kind":"tax_withholding","acquired":false,"shares":14735,"price":2.96,"value":43615.6,"ownership":{"direct":true},"balance_after":16614,"source":{"system":"sec-edgar","filing":"0000950138-20-000261","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013820000261/edgar.xml","form_type":"4"}},{"id":3195451,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-03-25T21:25:30.000Z","date":"2020-03-23","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units vesting as to 25% of the shares underlying the Restricted Stock Units on each anniversary date after the date of grant on the same day of the month as the date of grant, subject to continued service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units vesting as to 25% of the shares underlying the Restricted Stock Units on each anniversary date after the date of grant on the same day of the month as the date of grant, subject to continued service as a director."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001162194-20-000031","document":"wf-form4_158517151303374.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000031/wf-form4_158517151303374.xml","form_type":"4"}},{"id":3195450,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-25T21:25:30.000Z","date":"2020-03-23","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43343,"source":{"system":"sec-edgar","filing":"0001162194-20-000031","document":"wf-form4_158517151303374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219420000031/wf-form4_158517151303374.xml","form_type":"4"}},{"id":3500865,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-05T17:40:51.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":6796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 3, 2019."}],"balance_after":6796,"derivative":{"exercise_price":13.41,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":6796},"source":{"system":"sec-edgar","filing":"0001162194-19-000052","document":"wf-form4_155975643501913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000052/wf-form4_155975643501913.xml","form_type":"4"}},{"id":3500864,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-05T17:40:51.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":3987,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units that vest in full on the earlier to occur of June 3, 2020 and one day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":40843,"source":{"system":"sec-edgar","filing":"0001162194-19-000052","document":"wf-form4_155975643501913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000052/wf-form4_155975643501913.xml","form_type":"4"}},{"id":3511440,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-24T20:22:54.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":31349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units that vest in their entirety as of the date of the Company's 2020 Annual General Meeting. The restricted stock units settle in ordinary shares upon vesting."}],"balance_after":31349,"source":{"system":"sec-edgar","filing":"0000950138-19-000325","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013819000325/edgar.xml","form_type":"4"}},{"id":3562593,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2019-04-04T17:14:00.000Z","date":"2019-04-02","kind":"disposition_to_issuer","acquired":false,"shares":293000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":0,"derivative":{"exercise_price":1.31,"underlying":"Common Stock","underlying_shares":293000},"source":{"system":"sec-edgar","filing":"0001209191-19-023685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119023685/doc4.xml","form_type":"4"}},{"id":3562592,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2019-04-04T17:14:00.000Z","date":"2019-04-02","kind":"disposition_to_issuer","acquired":false,"shares":263009,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":0,"derivative":{"exercise_price":4.4,"underlying":"Common Stock","underlying_shares":263009},"source":{"system":"sec-edgar","filing":"0001209191-19-023685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119023685/doc4.xml","form_type":"4"}},{"id":3562591,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2019-04-04T17:14:00.000Z","date":"2019-04-02","kind":"disposition_to_issuer","acquired":false,"shares":216500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":0,"derivative":{"exercise_price":4.05,"underlying":"Common Stock","underlying_shares":216500},"source":{"system":"sec-edgar","filing":"0001209191-19-023685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119023685/doc4.xml","form_type":"4"}},{"id":3562590,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2019-04-04T17:14:00.000Z","date":"2019-04-02","kind":"disposition_to_issuer","acquired":false,"shares":175000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":0,"derivative":{"exercise_price":5.6,"underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-19-023685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119023685/doc4.xml","form_type":"4"}},{"id":3562589,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2019-04-04T17:14:00.000Z","date":"2019-04-02","kind":"disposition_to_issuer","acquired":false,"shares":244648,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":0,"derivative":{"exercise_price":1.23,"underlying":"Common Stock","underlying_shares":244648},"source":{"system":"sec-edgar","filing":"0001209191-19-023685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119023685/doc4.xml","form_type":"4"}},{"id":3562588,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2019-04-04T17:14:00.000Z","date":"2019-04-02","kind":"disposition_to_issuer","acquired":false,"shares":61161,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":0,"derivative":{"exercise_price":1.48,"underlying":"Common Stock","underlying_shares":61161},"source":{"system":"sec-edgar","filing":"0001209191-19-023685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119023685/doc4.xml","form_type":"4"}},{"id":3562587,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2019-04-04T17:14:00.000Z","date":"2019-04-02","kind":"disposition_to_issuer","acquired":false,"shares":67277,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":0,"derivative":{"exercise_price":1.31,"underlying":"Common Stock","underlying_shares":67277},"source":{"system":"sec-edgar","filing":"0001209191-19-023685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119023685/doc4.xml","form_type":"4"}},{"id":3562586,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2019-04-04T17:14:00.000Z","date":"2019-04-02","kind":"disposition_to_issuer","acquired":false,"shares":195289,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":0,"derivative":{"exercise_price":1.31,"underlying":"Common Stock","underlying_shares":195289},"source":{"system":"sec-edgar","filing":"0001209191-19-023685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119023685/doc4.xml","form_type":"4"}},{"id":3562585,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2019-04-04T17:14:00.000Z","date":"2019-04-02","kind":"disposition_to_issuer","acquired":false,"shares":121000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these unvested restricted stock units vested automatically in accordance with their terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these unvested restricted stock units vested automatically in accordance with their terms and were cancelled and automatically converted into the right to receive the Merger Consideration in respect of each share of Issuer common stock underlying such awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":121000},"source":{"system":"sec-edgar","filing":"0001209191-19-023685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119023685/doc4.xml","form_type":"4"}},{"id":3562584,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-04-04T17:14:00.000Z","date":"2019-04-02","kind":"disposition_to_issuer","acquired":false,"shares":35576,"price":5.85,"value":208119.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated February 20, 2019, by and among the Immune Design Corp. (the \"Issuer\"), Merck Sharp & Dohme Corp., a New Jersey corporation (\"Parent\") and Cascade Merger Sub Inc., a Delaware corporation (\"Purchaser\"), on April 2, 2019, Purchaser merged with and into the Issuer (the \"Merger\"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent.  In connection with the Merger, the Issuer's common stock were cancelled and converted into the right to receive $5.85 in cash per share, less any required withholding, subject to the terms and conditions of the Merger Agreement (\"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-023685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119023685/doc4.xml","form_type":"4"}},{"id":3578565,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-26T21:49:13.000Z","date":"2019-03-23","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units of which 25% of the total number of shares underlying the Restricted Stock Units have vested and will continue to vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units of which 25% of the total number of shares underlying the Restricted Stock Units have vested and will continue to vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001162194-19-000023","document":"wf-form4_155363693881535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000023/wf-form4_155363693881535.xml","form_type":"4"}},{"id":3578564,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-26T21:49:13.000Z","date":"2019-03-23","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36856,"source":{"system":"sec-edgar","filing":"0001162194-19-000023","document":"wf-form4_155363693881535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000023/wf-form4_155363693881535.xml","form_type":"4"}},{"id":3657040,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-15T02:00:22.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":4522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Subject to the Reporting Person's continued service with the Issuer through each applicable vesting date, twenty-five percent (25%) of the shares underlying the Restricted Stock Units shall vest quarterly on the last day of each quarter during 2019."}],"balance_after":34356,"source":{"system":"sec-edgar","filing":"0001162194-19-000006","document":"wf-form4_155019600857226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219419000006/wf-form4_155019600857226.xml","form_type":"4"}},{"id":3701874,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-07T20:36:55.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":293000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One quarter of the shares underlying the option will vest on January 3, 2020, and the remainder of the shares underlying the option will vest at a rate of 1/24th per month thereafter, subject to the Reporting Person's continuous service through each such date."}],"balance_after":293000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":293000},"source":{"system":"sec-edgar","filing":"0001209191-19-002671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119002671/doc4.xml","form_type":"4"}},{"id":3701873,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-07T20:36:55.000Z","date":"2019-01-07","kind":"sale","acquired":false,"shares":13014,"price":1.5822,"value":20590.7508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan that was included in the Reporting Person's restricted stock unit agreements, dated January 4, 2016, January 4, 2017 and January 4, 2018, in order to satisfy a tax liability incurred upon the vesting of restricted stock units on January 4, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.55 to $1.63 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":156576,"source":{"system":"sec-edgar","filing":"0001209191-19-002671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119002671/doc4.xml","form_type":"4"}},{"id":3701872,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-07T20:36:55.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Immune Design Corp. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock unit shall vest in a series of three equal consecutive annual installments beginning on January 4, 2020, subject to the Reporting Person's continuous service through each such date."}],"balance_after":169590,"source":{"system":"sec-edgar","filing":"0001209191-19-002671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919119002671/doc4.xml","form_type":"4"}},{"id":3864458,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":96874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 169,529 shares of the issuer's common stock granted to the reporting person on January 4, 2016. In exchange, the reporting person received a replacement option, for 96,874 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twenty four (24) equal consecutive monthly installments beginning on August 17, 2018."}],"balance_after":96874,"derivative":{"exercise_price":4.4,"expiration_date":"2025-07-17","underlying":"Common Stock","underlying_shares":96874},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864457,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"disposition_to_issuer","acquired":false,"shares":169529,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 169,529 shares of the issuer's common stock granted to the reporting person on January 4, 2016. In exchange, the reporting person received a replacement option, for 96,874 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option provided for vesting of 1/4th of the shares underlying the option on January 4, 2017 and the remainder of the shares underlying the option at a rate of 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":19.39,"expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":169529},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864456,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":3127,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 5,471 shares of the issuer's common stock granted to the reporting person on January 4, 2016. In exchange, the reporting person received a replacement option, for 3,127 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twenty four (24) equal consecutive monthly installments beginning on August 17, 2018."}],"balance_after":3127,"derivative":{"exercise_price":4.4,"expiration_date":"2025-07-17","underlying":"Common Stock","underlying_shares":3127},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864455,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"disposition_to_issuer","acquired":false,"shares":5471,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 5,471 shares of the issuer's common stock granted to the reporting person on January 4, 2016. In exchange, the reporting person received a replacement option, for 3,127 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option provided for vesting of 1/4th of the shares underlying the option on January 4, 2017 and the remainder of the shares underlying the option at a rate of 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":19.39,"expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":5471},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864454,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 90,000 shares of the issuer's common stock granted to the reporting person on January 7, 2015. In exchange, the reporting person received a replacement option, for 60,000 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twenty four (24) equal consecutive monthly installments beginning on August 17, 2018."}],"balance_after":60000,"derivative":{"exercise_price":4.4,"expiration_date":"2025-07-17","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864453,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"disposition_to_issuer","acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 90,000 shares of the issuer's common stock granted to the reporting person on January 7, 2015. In exchange, the reporting person received a replacement option, for 60,000 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option provided for vesting of 37.5% of the option on each of October 30, 2016 and 2017 with the remainder of the shares underlying the option on October 30, 2018."}],"balance_after":0,"derivative":{"exercise_price":13,"expiration_date":"2025-10-30","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864452,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":48775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 97,550 shares of the issuer's common stock granted to the reporting person on January 7, 2015. In exchange, the reporting person received a replacement option, for 48,775 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twenty four (24) equal consecutive monthly installments beginning on August 17, 2018."}],"balance_after":48775,"derivative":{"exercise_price":4.4,"expiration_date":"2025-07-17","underlying":"Common Stock","underlying_shares":48775},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864451,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"disposition_to_issuer","acquired":false,"shares":97550,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 97,550 shares of the issuer's common stock granted to the reporting person on January 7, 2015. In exchange, the reporting person received a replacement option, for 48,775 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option provided for 1/4th of the shares underlying the option on January 1, 2016 and the remainder of the shares at a rate of 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":31,"expiration_date":"2025-01-07","underlying":"Common Stock","underlying_shares":97550},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864450,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":1225,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 2,450 shares of the issuer's common stock granted to the reporting person on January 7, 2015. In exchange, the reporting person received a replacement option, for 1,225 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twenty four (24) equal consecutive monthly installments beginning on August 17, 2018."}],"balance_after":1225,"derivative":{"exercise_price":4.4,"expiration_date":"2025-07-17","underlying":"Common Stock","underlying_shares":1225},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864449,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"disposition_to_issuer","acquired":false,"shares":2450,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 2,450 shares of the issuer's common stock granted to the reporting person on January 7, 2015. In exchange, the reporting person received a replacement option, for 1,225 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option provided for 1/4th of the shares underlying the option on January 1, 2016 and the remainder of the shares at a rate of 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":31,"expiration_date":"2025-01-07","underlying":"Common Stock","underlying_shares":2450},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864448,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":44512,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 66,767 shares of the issuer's common stock granted to the reporting person on June 23, 2014. In exchange, the reporting person received a replacement option, for 44,512 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twenty four (24) equal consecutive monthly installments beginning on August 17, 2018."}],"balance_after":44512,"derivative":{"exercise_price":4.4,"expiration_date":"2025-07-17","underlying":"Common Stock","underlying_shares":44512},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864447,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"disposition_to_issuer","acquired":false,"shares":66767,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 66,767 shares of the issuer's common stock granted to the reporting person on June 23, 2014. In exchange, the reporting person received a replacement option, for 44,512 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option provided for vesting of 1/4th of the shares underlying the option on June 23, 2015 and the remainder of the shares at a rate of 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":8.92,"expiration_date":"2024-06-23","underlying":"Common Stock","underlying_shares":66767},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864446,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":8496,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,743 shares of the issuer's common stock granted to the reporting person on June 23, 2014. In exchange, the reporting person received a replacement option, for 8,496 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twenty four (24) equal consecutive monthly installments beginning on August 17, 2018."}],"balance_after":8496,"derivative":{"exercise_price":4.4,"expiration_date":"2025-07-17","underlying":"Common Stock","underlying_shares":8496},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3864445,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-07-19T18:05:22.000Z","date":"2018-07-17","kind":"disposition_to_issuer","acquired":false,"shares":12743,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,743 shares of the issuer's common stock granted to the reporting person on June 23, 2014. In exchange, the reporting person received a replacement option, for 8,496 shares, having an exercise price of $4.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option provided for vesting of 1/4th of the shares underlying the option on June 23, 2015 and the remainder of the shares at a rate of 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":8.92,"expiration_date":"2024-06-23","underlying":"Common Stock","underlying_shares":12743},"source":{"system":"sec-edgar","filing":"0001209191-18-043396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118043396/doc4.xml","form_type":"4"}},{"id":3911031,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-02T00:54:27.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":10600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/12th of the shares subject to the Option will vest monthly, subject to continued service as a director, such that the Option will be fully vested on May 31, 2019."}],"balance_after":10600,"derivative":{"exercise_price":5.57,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":10600},"source":{"system":"sec-edgar","filing":"0001162194-18-000074","document":"wf-form4_152790080790416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000074/wf-form4_152790080790416.xml","form_type":"4"}},{"id":3911030,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-02T00:54:27.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 13, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 13, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001162194-18-000074","document":"wf-form4_152790080790416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000074/wf-form4_152790080790416.xml","form_type":"4"}},{"id":3911029,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-02T00:54:27.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 1, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 1, 2017, the Reporting Person was granted Restricted Stock Units, vesting fully on the earlier to occur of: (i) one day prior to the date of the next annual meeting of the stockholders of the Company; or (ii) August 1, 2018, subject to continued service as a director through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001162194-18-000074","document":"wf-form4_152790080790416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000074/wf-form4_152790080790416.xml","form_type":"4"}},{"id":3911028,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-02T00:54:27.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":6100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"shares","element":"transactionShares","label":"F2","text":"All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) May 31, 2019, in each case subject to recipient's continued service as a director through the applicable vest date."}],"balance_after":29834,"source":{"system":"sec-edgar","filing":"0001162194-18-000074","document":"wf-form4_152790080790416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000074/wf-form4_152790080790416.xml","form_type":"4"}},{"id":3911027,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-02T00:54:27.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23734,"source":{"system":"sec-edgar","filing":"0001162194-18-000074","document":"wf-form4_152790080790416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000074/wf-form4_152790080790416.xml","form_type":"4"}},{"id":3911026,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-02T00:54:27.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20734,"source":{"system":"sec-edgar","filing":"0001162194-18-000074","document":"wf-form4_152790080790416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000074/wf-form4_152790080790416.xml","form_type":"4"}},{"id":3983135,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-03-27T00:57:31.000Z","date":"2018-03-23","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units, of which 25% of the total number of shares underlying the Restricted Stock Units have vested and will continue to vest on each anniversary after the date of grant on the same day of the month as the date of grant until fully vested, subject to continued service as a director through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 23, 2017, the Reporting Person was granted 10,000 Restricted Stock Units, of which 25% of the total number of shares underlying the Restricted Stock Units have vested and will continue to vest on each anniversary after the date of grant on the same day of the month as the date of grant until fully vested, subject to continued service as a director through each such date."}],"balance_after":7500,"derivative":{"exercise_date":"2018-03-23","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001162194-18-000044","document":"wf-form4_152211223751732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000044/wf-form4_152211223751732.xml","form_type":"4"}},{"id":3983134,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-27T00:57:31.000Z","date":"2018-03-23","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15734,"source":{"system":"sec-edgar","filing":"0001162194-18-000044","document":"wf-form4_152211223751732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000044/wf-form4_152211223751732.xml","form_type":"4"}},{"id":4055266,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-15T22:53:48.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":5952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Subject to the Reporting Person's continued service with the Issuer through each applicable vesting date, twenty-five percent (25%) of the shares underlying the Restricted Stock Units shall vest quarterly on the last day of each quarter during 2018."}],"balance_after":13234,"source":{"system":"sec-edgar","filing":"0001162194-18-000014","document":"wf-form4_151873521437770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000014/wf-form4_151873521437770.xml","form_type":"4"}},{"id":4104179,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-08T20:21:06.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":216500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One quarter of the shares underlying the option will vest on January 4, 2019, and the remainder of the shares underlying the option will vest at a rate of 1/24th per month thereafter, subject to the Reporting Person's continuous service through each such date."}],"balance_after":216500,"derivative":{"exercise_price":4.05,"expiration_date":"2028-01-04","underlying":"Common Stock","underlying_shares":216500},"source":{"system":"sec-edgar","filing":"0001209191-18-002810","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118002810/doc4.xml","form_type":"4"}},{"id":4104178,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-08T20:21:06.000Z","date":"2018-01-05","kind":"sale","acquired":false,"shares":7970,"price":4.1715,"value":33246.855,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan that was included in the Reporting Person's restricted stock unit agreements, dated January 4, 2016 and January 4, 2017, in order to satisfy a tax liability incurred upon the vesting of restricted stock units on January 4, 2018."},{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan that was included in the Reporting Person's restricted stock unit agreements, dated January 4, 2016 and January 4, 2017, in order to satisfy a tax liability incurred upon the vesting of restricted stock units on January 4, 2018."}],"balance_after":106590,"source":{"system":"sec-edgar","filing":"0001209191-18-002810","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118002810/doc4.xml","form_type":"4"}},{"id":4104177,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-01-08T20:21:06.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":46500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Immune Design Corp. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units shall vest in a series of three equal consecutive annual installments beginning on January 4, 2019, subject to the Reporting Person's continuous service through each such date."}],"balance_after":114560,"source":{"system":"sec-edgar","filing":"0001209191-18-002810","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919118002810/doc4.xml","form_type":"4"}},{"id":4112783,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-01-03T21:51:49.000Z","date":"2017-12-31","kind":"exercise","acquired":false,"shares":3641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) vested on December 31, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) vested on December 31, 2017."}],"balance_after":0,"derivative":{"exercise_date":"2017-12-31","underlying":"Common Stock","underlying_shares":3641},"source":{"system":"sec-edgar","filing":"0001162194-18-000005","document":"wf-form4_151501629519980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000005/wf-form4_151501629519980.xml","form_type":"4"}},{"id":4112782,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T21:51:49.000Z","date":"2017-12-31","kind":"exercise","acquired":true,"shares":3641,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7282,"source":{"system":"sec-edgar","filing":"0001162194-18-000005","document":"wf-form4_151501629519980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219418000005/wf-form4_151501629519980.xml","form_type":"4"}},{"id":4197919,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-10-03T00:55:16.000Z","date":"2017-09-30","kind":"exercise","acquired":false,"shares":3641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017 subject to serving as a director through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units vested on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017 subject to serving as a director through such date."}],"balance_after":3641,"derivative":{"exercise_date":"2017-09-30","underlying":"Common Stock","underlying_shares":3641},"source":{"system":"sec-edgar","filing":"0001162194-17-000152","document":"wf-form4_150699210164382.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000152/wf-form4_150699210164382.xml","form_type":"4"}},{"id":4197918,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T00:55:16.000Z","date":"2017-09-30","kind":"exercise","acquired":true,"shares":3641,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3641,"source":{"system":"sec-edgar","filing":"0001162194-17-000152","document":"wf-form4_150699210164382.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000152/wf-form4_150699210164382.xml","form_type":"4"}},{"id":4209516,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-15T01:06:49.000Z","date":"2017-09-13","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the total number of shares subject to the Option will vest each month after the Vesting Commencement Date, on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the Option will be fully vested one year following the Vesting Commencement Date, subject to recipient continuing to serve as a director of the Company through each such vesting date. \"Vesting Commencement Date\" shall mean August 1, 2017."}],"balance_after":3000,"derivative":{"exercise_price":5.44,"expiration_date":"2027-08-01","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001162194-17-000131","document":"wf-form4_150543759473189.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000131/wf-form4_150543759473189.xml","form_type":"4"}},{"id":4209515,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-09-15T01:06:49.000Z","date":"2017-09-13","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) August 1, 2018, in each case subject to recipient's continued service as a director through the applicable vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of (i) one day prior to the date of the next annual meeting of the stockholders of the Company or (ii) August 1, 2018, in each case subject to recipient's continued service as a director through the applicable vest date."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001162194-17-000131","document":"wf-form4_150543759473189.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000131/wf-form4_150543759473189.xml","form_type":"4"}},{"id":4237935,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-10T20:45:40.000Z","date":"2017-08-08","kind":"grant","acquired":true,"shares":7282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units will vest on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017, in each case subject to serving as a director through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Fifty percent (50%) of the shares underlying the Restricted Stock Units will vest on September 30, 2017, and the remaining fifty percent (50%) will vest on December 31, 2017, in each case subject to serving as a director through such date."}],"balance_after":7282,"derivative":{"underlying":"Common Stock","underlying_shares":7282},"source":{"system":"sec-edgar","filing":"0001162194-17-000111","document":"wf-form4_150239792599532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000111/wf-form4_150239792599532.xml","form_type":"4"}},{"id":4245928,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-03T00:32:23.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the shares subject to the Option will vest monthly, subject to continued service as a director, such that the Option will be fully vested on August 1, 2018."}],"balance_after":5000,"derivative":{"exercise_price":3.43,"expiration_date":"2027-08-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001162194-17-000082","document":"wf-form4_150172032970669.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000082/wf-form4_150172032970669.xml","form_type":"4"}},{"id":4245927,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-03T00:32:23.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 1, 2018, subject to continued service as a director  through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All shares underlying the Restricted Stock Units will fully vest on the earlier to occur of one day prior to the date of the next annual meeting of the stockholders of the Company or August 1, 2018, subject to continued service as a director  through the vesting date."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001162194-17-000082","document":"wf-form4_150172032970669.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000082/wf-form4_150172032970669.xml","form_type":"4"}},{"id":4371664,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-27T17:25:28.000Z","date":"2017-03-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Option will vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director."}],"balance_after":15000,"derivative":{"exercise_price":5.52,"expiration_date":"2027-03-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001162194-17-000031","document":"wf-form4_149063551466888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000031/wf-form4_149063551466888.xml","form_type":"4"}},{"id":4371663,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-03-27T17:25:28.000Z","date":"2017-03-23","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying the Restricted Stock Units will vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"25% of the shares underlying the Restricted Stock Units will vest each anniversary after the date of grant on the same day of the month as the date of grant, subject to continued service as a director."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001162194-17-000031","document":"wf-form4_149063551466888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000116219417000031/wf-form4_149063551466888.xml","form_type":"4"}},{"id":4496313,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-06T21:32:17.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One quarter of the shares underlying the option will vest on January 4, 2018, and the remainder of the shares underlying the option will vest at a rate of 1/36th per month thereafter, subject to the Reporting Person's continuous service through each such date."}],"balance_after":175000,"derivative":{"exercise_price":5.6,"expiration_date":"2027-01-04","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-17-002805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919117002805/doc4.xml","form_type":"4"}},{"id":4496312,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-06T21:32:17.000Z","date":"2017-01-04","kind":"sale","acquired":false,"shares":3940,"price":5.35,"value":21079.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan that was included in the Reporting Person's restricted stock unit agreement, dated January 4, 2016, in order to satisfy a tax liability incurred upon the vesting of restricted stock units on January 4, 2017."},{"field":"shares","element":"transactionShares","label":"F3","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan that was included in the Reporting Person's restricted stock unit agreement, dated January 4, 2016, in order to satisfy a tax liability incurred upon the vesting of restricted stock units on January 4, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $5.25 to $5.42 per share, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":68060,"source":{"system":"sec-edgar","filing":"0001209191-17-002805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919117002805/doc4.xml","form_type":"4"}},{"id":4496311,"issuer":{"id":158527,"kind":"organization","name":"IMMUNE DESIGN CORP.","symbol":"IMDZ"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-06T21:32:17.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Immune Design Corp. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"One quarter of the total restricted stock units vest annually beginning January 4, 2018, subject to the Reporting Person's continuous service\nthrough each such date."}],"balance_after":72000,"source":{"system":"sec-edgar","filing":"0001209191-17-002805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437786/000120919117002805/doc4.xml","form_type":"4"}}]}